{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:50:14Z","timestamp":1761648614049},"reference-count":21,"publisher":"SLACK, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[2004,1]]},"abstract":"<jats:p>ABSTRACT<\/jats:p>\n          <jats:p>Purpose: To describe the surveillance, results of screening, and treatment of retinopathy of prematurity (ROP) in a university hospital setting in southeast France.<\/jats:p>\n          <jats:p>Patients and Methods: Five hundred two premature infants were included in the screening protocol between January 1997 and December 1999. Criteria for inclusion in the study were a gestational age of 32 weeks or younger, a birth weight of less than 1,501 g, or both. The first fundus examination was performed between 4 and 6 weeks of life. Thereafter, fundus examination was performed in the absence of ROP every 2 weeks until complete retinal vasculature developed, gestational age of 50 weeks, or death. Examination was weekly in cases of retinopathy, biweekly if progression was ascertained, and less frequent only if regression was evident. Hospital records were reviewed to assess the presence or absence and eventual degree of ROP.<\/jats:p>\n          <jats:p>Results: Stage 1 was observed in 32 infants, and stage 2 in 11 infants; all of these cases regressed. Three cases of bilateral stage 3 (two threshold and one prethreshold) disease underwent diode laser peripheral retinal ablation and regressed. One infant with bilateral stage 3 disease who underwent peripheral cryoablative surgery progressed to stage 4A in one eye and 4B in the other eye and then underwent scierai buckling surgery in the second eye.<\/jats:p>\n          <jats:p>Conclusions: Despite survival increasing with improved neonatal intensive care, the incidence of ROP does not appear to be increasing. In our center, the incidence appears to be lower than previously reported.<\/jats:p>\n          <jats:p>J Pediatr Ophthalmol Strabismus 2004;41:31-34.<\/jats:p>","DOI":"10.3928\/0191-3913-20040101-08","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T17:21:18Z","timestamp":1548264078000},"page":"31-34","source":"Crossref","is-referenced-by-count":6,"title":["Screening for Retinopathy of Prematurity: Results of a Retrospective 3-Year Study of 502 Infants"],"prefix":"10.3928","volume":"41","author":[{"given":"John G","family":"Conrath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve J","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Forzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Millet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Lacroze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Ridings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1. Hussain N Clive J Bhandari V. Current incidence of retinopathy of prematurity 1989-1997. Pediatrics 1999;104:e26.","DOI":"10.1542\/peds.104.3.e26"},{"key":"e_1_3_1_3_1","unstructured":"2. Palmer EA FJynn }T Hardy RJ et al. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:I6281640."},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"3. Saunders RA Donahue ML Christmann LM et al. Racial variation in retinopathy of prematurity. Arch Ophthalmol 1997; 115:604-608.","DOI":"10.1001\/archopht.1997.01100150606005"},{"key":"e_1_3_1_5_1","unstructured":"4. The Committee for Classification of Retinopathy of Prematurity. An international classification for retinopathy of prematurity. Arch Ophthalmol 1984;102:1 130-1 134."},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Subhani M Combs A Weber P Gerontis C De Cristofaro JD. Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants. Pediatrics 2001;107:656-659.","DOI":"10.1542\/peds.107.4.656"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Schalij-Delfos NE Zijlmans BL Wittebol-Post D Tan KE Cats BP. Screening for rcdnopathy of prematurity: do former guidelines still apply? J Pediatr Ophthalmol Strabismus 1996;33:35-38.","DOI":"10.3928\/0191-3913-19960101-10"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. Goble RR Jones HS Fielder AR. Are we screening too many babies for retinopathy of prematurity? Eye 1997;ll(part 4):509514.","DOI":"10.1038\/eye.1997.136"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Giu TR Easdown J Outerbridge EW Aranda VJ. Risk factors in rettolental fibroplasia. Pediatr\u00eca 1980;65:1096-1100.","DOI":"10.1542\/peds.65.6.1096"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"9. Hammer ME Mullen PW Ferguson JG Pai S Cosby C Jackson KL. Logistic analysis of risk factors in acute retinopathy of prematurity. Am] Ophthalmol 1986;102:l-6.","DOI":"10.1016\/0002-9394(86)90200-X"},{"key":"e_1_3_1_11_1","doi-asserted-by":"crossref","unstructured":"10. Kinsey VE Arnold HJ Kalina RE et al. PaO2 levels and retrolental fibroplasia: a report of die cooperative study. Pediatrics 1977;60:655-668.","DOI":"10.1542\/peds.60.5.655"},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Brown DR Biglan AW Stretavsky MM. Retinopathy of prematuity: die relationship with intraventicular hemorrhage and bronchopulmonary dysplasia. J Pediatr Ophthalmol Strabismus 1990;27:268-271.","DOI":"10.3928\/0191-3913-19900901-13"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Clark C Gibbs JA Maniello R Outerbridgc EW Aranda JV. Blood transfusion: a possible risk factor in retrolental fibroplasia. Acta Pediatr Scand 1981;70:537-539.","DOI":"10.1111\/j.1651-2227.1981.tb05736.x"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Mirrai M Dhanireddy R Higgins RD. Candida sepsis and association with retinopathy of prematurity. Pediatr\u00eca 1998;101(4 part l):654-657.","DOI":"10.1542\/peds.101.4.654"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"14. Bancakri E Flynn J Goldberg RN et al Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatr\u00eca 1987;79:663-669.","DOI":"10.1542\/peds.79.5.663"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. Higgins RD Mendelsohn AL DeFeo MJ Ucsel R HendricksMunoz KD. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 1998;ll6:601-605.","DOI":"10.1001\/archopht.116.5.601"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"16. Repka MX Hudak ML Parsa CR Tielsch JM. Calf lung surfactant extract prophylaxis and retinopathy of prematurity. Ophthalmology 1992;99:531-536.","DOI":"10.1016\/S0161-6420(92)31937-2"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. Repka MX Hardy RJ Phelps DL1 Summers CG. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol 1993:111:618-620.","DOI":"10.1001\/archopht.1993.01090050052027"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"18. Darlow BA Horwood LJ Clemett RS. Retinopadiy of prematurity: risk factors in a prospective population-based study. Paediatr Perinat Epidemial 1992;6:62-80.","DOI":"10.1111\/j.1365-3016.1992.tb00747.x"},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"19. Mizoguchi MB Chu TG Murphy FM Willits N Morse LS. Dopamine use is an indicator for the development of threshold retinopathy of prematurity. Br J Ophthalmol 1999;83:425-428.","DOI":"10.1136\/bjo.83.4.425"},{"key":"e_1_3_1_21_1","doi-asserted-by":"crossref","unstructured":"20. Bullard SR Donahue SP Feman SS Sinatra RB Walsh WF. The decreasing incidence and severity of retinopathy of prematurity. J AAPOS 1999;3:32 1-322.","DOI":"10.1016\/S1091-8531(99)70094-7"},{"key":"e_1_3_1_22_1","unstructured":"21. BlairBM O'halloran HS Pauly TH Stevens JL. Decreased incidence of rerinopathy of prematurity 1 995- 1 997. J AAPOS 200 1 ; 5:118-122."}],"container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:52:43Z","timestamp":1683093163000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0191-3913-20040101-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.3928\/0191-3913-20040101-08"],"URL":"https:\/\/doi.org\/10.3928\/0191-3913-20040101-08","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"value":"0191-3913","type":"print"},{"value":"1938-2405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}